25 November 2015 - Two drugs sold by Valeant Pharmaceuticals International to treat cancer-related skin conditions increased in price by about 1,700 percent over the last six years, according to a newly published survey that found big increases in the cost of dermatology drugs across the board.

For more details, go to: http://www.nytimes.com/2015/11/26/business/2-valeant-dermatology-drugs-lead-steep-price-increases-study-finds.html?emc=edit_th_20151126&nl=todaysheadlines&nlid=20088616&_r=0